News, Media & Publications

Congress Says ‘Yes’ to Fast Track FDA Approvals

Posted in News on 12.9.2016

Last week Congress passed legislation addressing questions of healthcare regulation and public health funding. The 21st Century Cures Bill was able to gain easy approval in both the House and Senate because it contains provisions that appeal to both sides of the aisle and to various industry and public interest groups. One of the most …

Bill to Ease FDA Approval Draws Praise and Rebuke

Posted in News on 12.1.2016

Alosa Health founder Dr. Jerry Avorn was quoted in the Wall Street Journal regarding a healthcare bill scheduled for a vote in the House next week. The bill in question covers a breadth of topics from funding for biomedical research to opioid addiction to the FDA’s regulatory processes.  The proposal to ease FDA standards for …

Healthcare Bill to Fund Research, Overhaul FDA Regs

Posted in News on 11.30.2016

The $6.3 billion bill that has been called “parting gift” to Vice President Joe Biden contains a smorgasbord of healthcare related provisions, including a commitment to additional funding for cancer research through the National Institutes of Health (NIH). Notably, Biden’s son died of brain cancer last year. Other topics that the bill touches on include …

PACE Launches Hypertension Training

Posted in Updates on 11.15.2016

Alosa Health’s newly updated hypertension training module launched recently through the PACEprogram in Pennsylvania, providing guidance on the latest evidence on hypertension treatment goals and recommendations for therapy. In keeping with our mission to deliver the most up-to-date evidence available, our module encompasses recommendations from landmark trials such as ACCORD and SPRINT, neither of which were included in the most recent consensus guidelines …

Alosa Wins PrEP Bid in Shelby County, TN

Posted in Updates on 11.1.2016

This year Alosa Health will kick-off a new program based in Shelby County, TN to support the county health department’s HIV prevention initiatives. The program will focus on educating primary care providers in high-risk areas about the use of PrEP, or pre-exposure prophylaxis, as an HIV prevention strategy. This initiative is supported by funding through the CDC’s Project …

The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform

Posted in Publications on 9.6.2016

JAMA. 2016;316(8)858-871 High prescription drug prices are increasingly straining the budgets of patients, payors and healthcare systems in the United States. In this JAMA clinical review, Drs. Avorn, Kesselheim and Sarpartwari describe the origins for high drug prices and recommend policy options to help contain these rising costs. They find that per capita prescription drug …

Forbidden and Permitted Statements about Medications – Loosening the Rules

Posted in Publications on 9.10.2015

NEJM. 2015;373(10)967-973 The promotion of drugs by manufacturers for uses not previously approved by the FDA (aka off-label use) is controversial because it may lead to more patients being exposed to medicines with an uncertain risk-benefit profile. In an article published in the New England Journal of Medicine, Drs. Avorn, Kesselheim and Sarpartwari describe a …

BALANCED INFORMATION FOR BETTER CARE